VERACYTE, INC. Retained Earnings
VERACYTE, INC. (VCYT) had Retained Earnings of -$323.43 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-31
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$323.43M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$348.92M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$377.63M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$418.78M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$323.43M 10-Q · filed 2026-07-31 |
| 2026-03-31 | -$348.92M 10-Q · filed 2026-05-06 |
| 2025-12-31 | -$377.63M 10-Q · filed 2026-07-31 |
| 2025-09-30 | -$418.78M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$437.92M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$436.94M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$443.98M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$449.10M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$464.25M 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$469.99M 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$468.12M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$439.83M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$410.21M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$401.81M 10-Q · filed 2023-05-05 |
| 2022-12-31 | -$393.72M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$389.87M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$381.15M 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$371.62M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$357.16M 10-K · filed 2023-03-01 |
| 2021-09-30 | -$346.63M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$332.50M 10-Q · filed 2021-07-29 |
| 2021-03-31 | -$323.46M 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$281.59M 10-K · filed 2022-02-28 |
| 2020-09-30 | -$273.55M 10-Q · filed 2020-11-02 |
| 2020-06-30 | -$269.43M 10-Q · filed 2020-07-30 |
| 2020-03-31 | -$258.40M 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$246.69M 10-K · filed 2021-02-22 |
| 2019-09-30 | -$239.23M 10-Q · filed 2019-10-22 |
| 2019-06-30 | -$238.50M 10-Q · filed 2019-07-30 |
| 2019-03-31 | -$236.00M 10-Q · filed 2019-04-30 |
| 2018-12-31 | -$234.09M 10-K · filed 2020-02-25 |
| 2018-09-30 | -$230.98M 10-Q · filed 2018-10-29 |
| 2018-06-30 | -$226.51M 10-Q · filed 2018-07-23 |
| 2018-03-31 | -$220.26M 10-Q · filed 2018-05-01 |
| 2017-12-31 | -$211.09M 10-K · filed 2019-02-25 |
| 2017-09-30 | -$202.65M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$195.60M 10-Q · filed 2017-07-31 |
| 2017-03-31 | -$188.30M 10-Q · filed 2017-05-03 |
| 2016-12-31 | -$180.08M 10-K · filed 2018-02-27 |
| 2016-09-30 | -$175.68M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$170.04M 10-Q · filed 2016-08-03 |
| 2016-03-31 | -$158.80M 10-Q · filed 2016-05-05 |
| 2015-12-31 | -$148.73M 10-K · filed 2017-03-01 |
| 2015-09-30 | -$140.71M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$131.77M 10-Q · filed 2015-08-13 |
| 2015-03-31 | -$122.63M 10-Q · filed 2015-05-15 |
| 2014-12-31 | -$115.02M 10-K · filed 2016-03-14 |
| 2014-09-30 | -$106.88M 10-Q · filed 2014-11-13 |
| 2014-06-30 | -$98.98M 10-Q · filed 2014-08-14 |
| 2014-03-31 | -$92.32M 10-Q · filed 2014-05-09 |
| 2013-12-31 | -$85.65M 10-K · filed 2015-03-25 |
| 2013-09-30 | -$79.76M 10-Q · filed 2013-11-25 |
| 2012-12-31 | -$60.07M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |